Skip to main content

PFIZER INC

For the period ended Sep 29, 2024. Filed Nov 4, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 29, 2024 · Filed Nov 4, 2024

PFE$29.36+0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Comprehensive Income

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)

Three Months EndedNine Months Ended
(MILLIONS)September 29,2024October 1,2023September 29,2024October 1,2023
Net income/(loss) before allocation to noncontrolling interests$4,473$(2,376)$7,644$5,518
Foreign currency translation adjustments, net131(109)200234
Unrealized holding gains/(losses) on derivative financial instruments, net(303)40841519
Reclassification adjustments for (gains)/losses included in net income/(loss)(a)(175)(67)(334)73
(477)341(293)593
Unrealized holding gains/(losses) on available-for-sale securities, net59(83)(17)30
Reclassification adjustments for (gains)/losses included in net income/(loss)(b)(6)5180(442)
54(32)63(411)
Reclassification adjustments related to amortization of prior service costs and other, net(27)(29)(83)(88)
Reclassification adjustments related to curtailments of prior service costs and other, net(2)(1)(2)(14)
(29)(30)(85)(102)
Other comprehensive income/(loss), before tax(322)170(115)313
Tax provision/(benefit) on other comprehensive income/(loss)(157)36(81)(17)
Other comprehensive income/(loss) before allocation to noncontrolling interests$(166)$134$(35)$330
Comprehensive income/(loss) before allocation to noncontrolling interests$4,307$(2,242)$7,609$5,848
Less: Comprehensive income/(loss) attributable to noncontrolling interests(3)4(2)23
Comprehensive income/(loss) attributable to Pfizer Inc.$4,310$(2,247)$7,611$5,826

(a)Reclassified into Other (income)/deductions—netand Cost of sales. See Note 7E.

(b)Reclassified into Other (income)/deductions—net.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.